Table 3:
MALES | NON-HISPANIC WHITE | ALL HISPANIC | MEXICAN | CUBAN | PUERTO RICAN | CENTRAL or SOUTH AMERICAN | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cancer Site | n | AMR1 (95% CI) | SMR2 | n | AMR1 (95% CI) | SMR2 | n | AMR1 (95% CI) | SMR2 | n | AMR1 (95% CI) | SMR2 | n | AMR1 (95% CI) | SMR2 | n | AMR1 (95% CI) | SMR2 |
All Sites | 2389032 | 220.42 (220.14-220.71) | 1 | 151385 | 153.68 (152.84-154.53) | 0.69 (0.69-0.69) | 83236 | 154.72 (153.55-155.89) | 0.69 (0.69-0.69) | 16570 | 178.62 (175.89-181.36) | 0.81 (0.8-0.82) | 19034 | 179.73 (176.92-182.54) | 0.84 (0.82-0.85) | 10521 | 91.19 (89.09-93.29) | 0.4 (0.39-0.41) |
Lung | 736913 | 66.69 (66.54-66.85) | 1 | 29246 | 31.73 (31.34-32.12) | 0.44 (0.44-0.45) | 14634 | 30.51 (29.98-31.04) | 0.41 (0.4-0.41) | 4737 | 50.26 (48.82-51.69) | 0.75 (0.73-0.78) | 3969 | 37.59 (36.32-38.85) | 0.57 (0.55-0.59) | 1546 | 14.63 (13.79-15.47) | 0.20 (0.10-0.21) |
Prostate | 218687 | 21.68 (21.59-21.77) | 1 | 14212 | 19.1 (18.77-19.43) | 0.89 (0.88-0.91) | 7361 | 18.69 (18.25-19.14) | 0.87 (0.85-0.89) | 1929 | 21.51 (20.54-22.47) | 1 (0.95-1.04) | 1651 | 21.32 (20.23-22.42) | 1 (0.95-1.05) | 1038 | 13.95 (13.02-14.88) | 0.64 (0.60-0.68) |
Colon and rectum | 213040 | 19.74 (19.65-19.82) | 1 | 15892 | 16.06 (15.79-16.34) | 0.81 (0.79-0.82) | 8670 | 15.86 (15.49-16.23) | 0.8 (0.79-0.82) | 1813 | 19.54 (18.64-20.44) | 1 (0.95-1.04) | 2033 | 19.8 (18.85-20.75) | 1 (0.96-1.05) | 969 | 7.81 (7.22-8.41) | 0.41 (0.38-0.44) |
Pancreas | 139941 | 12.66 (12.59-12.73) | 1 | 9714 | 9.72 (9.51-9.93) | 0.75 (0.74-0.77) | 5355 | 9.81 (9.52-10.1) | 0.76 (0.74-0.78) | 1057 | 11.28 (10.6-11.96) | 0.89 (0.84-0.95) | 1092 | 10.01 (9.36-10.66) | 0.81 (0.76-0.86) | 711 | 6.3 (5.75-6.84) | 0.46 (0.42-0.49) |
Liver | 81255 | 7.17 (7.12-7.22) | 1 | 13850 | 12.45 (12.22-12.68) | 1.7 (1.67-1.73) | 8397 | 14.01 (13.68-14.34) | 1.86 (1.82-1.9) | 720 | 7.68 (7.12-8.25) | 1.07 (0.99-1.15) | 2123 | 16.71 (15.94-17.48) | 2.51 (2.41-2.62) | 763 | 6.13 (5.62-6.65) | 0.75 (0.69-0.8) |
Stomach | 43192 | 4 (3.96-4.04) | 1 | 7996 | 7.79 (7.6-7.98) | 1.97 (1.93-2.02) | 4610 | 8.15 (7.89-8.42) | 2.07 (2.01-2.13) | 429 | 4.67 (4.22-5.11) | 1.16 (1.05-1.27) | 834 | 8.41 (7.78-9.03) | 2 (1.86-2.14) | 965 | 7.58 (7-8.16) | 1.97 (1.84-2.09) |
Leukemia | 105913 | 10.09 (10.03-10.16) | 1 | 7615 | 6.28 (6.12-6.44) | 0.74 (0.72-0.76) | 4462 | 6.19 (5.97-6.41) | 0.78 (0.75-0.8) | 645 | 7.07 (6.52-7.62) | 0.7 (0.65-0.75) | 764 | 6.7 (6.16-7.24) | 0.74 (0.68-0.79) | 712 | 4.81 (4.36-5.27) | 0.6 (0.55-0.64) |
NHL | 94053 | 8.84 (8.78-8.9) | 1 | 6725 | 6.54 (6.36-6.71) | 0.78 (0.76-0.8) | 3769 | 6.77 (6.52-7.01) | 0.79 (0.77-0.82) | 619 | 6.72 (6.19-7.25) | 0.76 (0.7-0.82) | 817 | 7.31 (6.75-7.86) | 0.92 (0.86-0.99) | 632 | 4.97 (4.49-5.45) | 0.62 (0.57-0.67) |
FEMALES | NHW | ALL HISPANIC | MEXICAN | CUBAN | PUERTO RICAN | CENTRAL or SOUTH AMERICAN | ||||||||||||
Site | n | AMR1 (95% CI) | SMR2 | n | AMR1 (95% CI) | SMR2 | n | AMR1 (95% CI) | SMR2 | n | AMR1 (95% CI) | SMR2 | n | AMR1 (95% CI) | SMR2 | n | AMR1 (95% CI) | SMR2 |
All Sites | 183994 | 157.33 (156.59-158.07) | 1 | 38978 | 106.49 (105.39-107.59) | 0.69 (0.68-0.69) | 72657 | 107.33 (106.51-108.15) | 0.7 (0.69-0.7) | 12559 | 103.87 (102.01-105.73) | 0.67 (0.66-0.68) | 16327 | 111.41 (109.64-113.17) | 0.72 (0.71-0.73) | 12873 | 69.715 (68.42-71.01) | 0.44 (0.44-0.45) |
Breast | 597825 | 23.11 (23.02-23.19) | 1 | 21651 | 15.05 (14.84-15.26) | 0.67 (0.66-0.68) | 11572 | 15.28 (14.99-15.58) | 0.69 (0.68-0.7) | 2026 | 17.56 (16.78-18.34) | 0.76 (0.73-0.79) | 2684 | 17.02 (16.36-17.69) | 0.75 (0.72-0.78) | 1947 | 9.11 (8.67-9.54) | 0.41 (0.39-0.43) |
Lung | 319254 | 23.11 (23.02-23.19) | 1 | 17662 | 14.32 (14.1-14.53) | 0.32 (0.32-0.33) | 8647 | 14.35 (14.03-14.66) | 0.31 (0.31-0.32) | 1947 | 16.05 (15.32-16.78) | 0.38 (0.36-0.39) | 2498 | 17.49 (16.78-18.19) | 0.4 (0.39-0.42) | 1366 | 8.12 (7.66-8.57) | 0.17 (0.16-0.18) |
Colon and rectum | 206599 | 14.06 (14-14.12) | 1 | 13088 | 10.34 (10.16-10.52) | 0.74 (0.72-0.75) | 6252 | 9.7 (9.45-9.95) | 0.7 (0.68-0.72) | 1680 | 13.36 (12.71-14.01) | 0.95 (0.91-1) | 1880 | 13.34 (12.72-13.96) | 0.96 (0.91-1) | 1077 | 6.16 (5.77-6.56) | 0.44 (0.41-0.46) |
Pancreas | 137154 | 9.46 (9.41-9.52) | 1 | 9560 | 7.82 (7.65-7.98) | 0.81 (0.79-0.82) | 5075 | 8.34 (8.1-8.57) | 0.86 (0.83-0.88) | 982 | 7.68 (7.19-8.17) | 0.83 (0.78-0.88) | 1022 | 7.41 (6.94-7.87) | 0.77 (0.72-0.82) | 931 | 5.7 (5.32-6.09) | 0.56 (0.53-0.6) |
Ovary | 42249 | 2.97 (2.94-3) | 1 | 7933 | 5.87 (5.74-6.01) | 0.67 (0.66-0.69) | 4311 | 6.24 (6.04-6.44) | 0.72 (0.69-0.74) | 683 | 5.86 (5.41-6.31) | 0.66 (0.61-0.71) | 810 | 5.5 (5.11-5.89) | 0.62 (0.57-0.66) | 818 | 4.1 (3.79-4.4) | 0.48 (0.45-0.51) |
Liver | 29096 | 2.01 (1.99-2.03) | 1 | 6877 | 5.52 (5.38-5.65) | 1.78 (1.74-1.83) | 4122 | 6.65 (6.44-6.87) | 2.11 (2.05-2.17) | 458 | 3.6 (3.26-3.93) | 1.27 (1.15-1.38) | 713 | 4.95 (4.58-5.32) | 1.67 (1.54-1.79) | 639 | 3.84 (3.53-4.16) | 1.18 (1.09-1.27) |
Stomach | 79045 | 5.56 (5.52-5.6) | 1 | 6015 | 4.46 (4.34-4.58) | 2.33 (2.28-2.39) | 3415 | 4.92 (4.74-5.09) | 2.62 (2.53-2.71) | 260 | 2.1 (1.84-2.36) | 1.04 (0.91-1.17) | 565 | 4.04 (3.69-4.38) | 1.99 (1.83-2.16) | 922 | 4.73 (4.4-5.06) | 2.57 (2.4-2.73) |
Leukemia | 121526 | 8.72 (8.67-8.77) | 1 | 5999 | 4.03 (3.92-4.14) | 0.8 (0.78-0.82) | 3308 | 3.99 (3.84-4.14) | 0.85 (0.82-0.88) | 547 | 4.54 (4.15-4.94) | 0.8 (0.73-0.87) | 641 | 4.17 (3.83-4.5) | 0.79 (0.73-0.86) | 622 | 3.12 (2.86-3.39) | 0.62 (0.57-0.67) |
NHL | 80204 | 5.47 (5.43-5.51) | 1 | 5599 | 4.44 (4.32-4.56) | 0.83 (0.81-0.85) | 3007 | 4.75 (4.57-4.93) | 0.89 (0.86-0.92) | 556 | 4.51 (4.12-4.89) | 0.8 (0.73-0.86) | 617 | 4.33 (3.98-4.69) | 0.83 (0.76-0.89) | 585 | 3.49 (3.19-3.79) | 0.64 (0.59-0.69) |
Average annual mortality rates (AMRs) are reported per 100,000 person-years. The numerator of the rate was determined by the total number of cancer deaths over the 10-year period in each sex-, Hispanic group- and site-specific stratum. The denominator is the 10-year sum of the sex- and Hispanic group-specific U.S population based on census data. Rates were directly standardized to the 2000 U.S. population age distribution to render them comparable across stratum.
Standardized mortality ratios (SMRs) were created by dividing the sum of the 10-year sex-, Hispanic group- and site-specific deaths by the “expected” number of deaths, as defined by the sum of the 10-year deaths for the sex- and site-specific NHW population (the reference population).